In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

Renovascular disease remains among the most prevalent and important causes of
secondary hypertension and renal dysfunction. Many lesions reduce perfusion pressure …

Background: Little is known about the efficacy and safety of renal artery stenting in patients
with atherosclerotic renal artery stenosis (ARAS) and impaired renal function. Objective: To …

Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk
factors, revascularization, and prognosis. Background Although atherosclerotic renovascular …

Learning Objectives After completing this course, the reader will be able to: Explain how
statins, used in the treatment of hypercholesterolemia, may be applicable to cancer …

Hypertension is a growing public health problem worldwide. Only 37% of American
hypertensives currently have their blood pressures controlled. Hypertension is traditionally …

A 73-year-old former smoker with a history of hypertension presents with shortness of
breath. His blood pressure is 160/75 mm Hg, and his serum creatinine level is 1.4 mg per …

Atheromatous renovascular disease (ARVD) is increasingly suspected and diagnosed, and
it commonly presents to several different clinical specialties. In this review, the epidemiology …

Background Atherosclerotic renal artery stenosis is the most common cause of secondary
hypertension. Balloon angioplasty with stenting is widely used for the treatment of …

Atherosclerosis is the primary cause of renal artery stenosis. Atherosclerotic renal artery
stenosis (ARAS) is associated with three clinical problems: renovascular hypertension …